Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%

Completed · Phase 3 · Has a placebo group

Conditions studied: Glaucoma, Open-Angle, Ocular Hypertension

In brief

Phase III study to compare the safety and efficacy of intraocular implants containing travoprost at two different elution rates versus Timolol Maleate Ophthalmic Solution, 0.5% (timolol) in reducing elevated intraocular pressure in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).

Key facts

Study ID

NCT03519386

Run by

Glaukos Corporation

People needed

590

Starts

2018-07-26

Expected to finish

2024-04-02

Last updated by the study team

2024-11-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with open-angle glaucoma or ocular hypertension.
• C/D ratio ≤ 0.8
• Zero to three preoperative ocular hypotensive medications

You may not qualify if…

• Active corneal inflammation or edema.
• Retinal disorders not associated with glaucoma.

Where it is running

• Vance Thompson Vision — Sioux Falls, South Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.